 |
 |
|
|
FDA
- Helping Alcoholics Stay Sober
-- Campral works to prevent relapses
MONDAY, Aug. 2 (HealthDayNews) -- The U.S. Food and Drug Administration has approved the first new drug to treat alcohol abuse in a decade.
Campral (acamprosate) is meant to prevent relapses among alcoholics who have stopped drinking. The agency warned that the drug may not work in people who are actively drinking at the start of treatment, or who are abusing other substances in addition to alcohol.
Exactly how the drug works isn't fully understood, the agency said. The medication is thought to act on the brain pathways that help foster alcohol abuse. In clinical trials, Campral proved "superior" to a nonmedicinal placebo in keeping recovering alcoholics from taking a drink, the agency said in a statement.
Common side effects noted during clinical studies included headache, diarrhea, flatulence, and nausea. The drug is produced by Lipha Pharmaceuticals of France.
To learn more about alcoholism, visit the National Institute on Alcohol Abuse and Alcoholism.
- -- Scott Roberts
-- Copyright © 2004 ScoutNews, LLC. All rights reserved.
-- This is a story from HealthDay, a service of ScoutNews, LLC.
Home | About Us | Contact Us | Site Index | Privacy Policy | Disclaimer | FOIA | Accessibility
Contact NWHIC
or call 1-800-994-WOMAN
NWHIC is a service of
the
U.S.
Department of Health and Human Services'
Office
on Women's Health